Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Shares Outstanding (Weighted Average) (2017 - 2022)

Historic Shares Outstanding (Weighted Average) for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $12.2 million.

  • Iterum Therapeutics' Shares Outstanding (Weighted Average) rose 42.17% to $12.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $12.2 million, marking a year-over-year increase of 42.17%. This contributed to the annual value of $10.9 million for FY2021, which is 58042.01% up from last year.
  • Latest data reveals that Iterum Therapeutics reported Shares Outstanding (Weighted Average) of $12.2 million as of Q3 2022, which was up 42.17% from $12.2 million recorded in Q2 2022.
  • Iterum Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $180.0 million for Q2 2021, and its period low was $197949.0 during Q1 2018.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $26.4 million, with a median of $14.0 million in 2018.
  • Per our database at Business Quant, Iterum Therapeutics' Shares Outstanding (Weighted Average) soared by 748464.71% in 2018 and then tumbled by 9320.94% in 2022.
  • Iterum Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $8.7 million in 2018, then skyrocketed by 66.22% to $14.5 million in 2019, then crashed by 88.97% to $1.6 million in 2020, then surged by 580.42% to $10.9 million in 2021, then increased by 12.32% to $12.2 million in 2022.
  • Its last three reported values are $12.2 million in Q3 2022, $12.2 million for Q2 2022, and $12.2 million during Q1 2022.